P669: ANALYSIS OF FACTORS INFLUENCING THE DECISION TO STOP TKI TREATMENT IN CML PATIENTS IN DEEP MOLECULAR RESPONSE

• Lukas Semerad,
• Daniela Žáčková,
• Petra Belohlavkova,
• Jaroslava Voglova,
• Pavel Žák,
• Edgar Faber,
• Tomas Papajik,
• Ivana Skoumalova,
• Michal Karas,
• Pavel Jindra,
• Hana Klamová,
• Cyril Salek,
• Dana Srbová,
• Hana Zizkova,
• Lukas Stejskal,
• Olga Cerna,
• Eduard Cmunt,
• Petra Cicatkova,
• Anezka Kvetkova,
• Tomas Hornak,
• Ivana Jeziskova,
• Tomas Jurcek,
• Barbora Weinbergerová,
• Jirina Prochazkova,
• Katerina Machova Polakova,
• Adam Svobodnik,
• Radka Stepanova,
• Jiri Mayer

Affiliations

Lukas Semerad

1 University Hospital Brno, Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic

Daniela Žáčková

1 University Hospital Brno, Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic

Petra Belohlavkova

3 University Hospital Hradec Kralove, The 4th Department of Internal Medicine, Hradec Kralove, Czech Republic

Jaroslava Voglova

3 University Hospital Hradec Kralove, The 4th Department of Internal Medicine, Hradec Kralove, Czech Republic

Pavel Žák

3 University Hospital Hradec Kralove, The 4th Department of Internal Medicine, Hradec Kralove, Czech Republic

Edgar Faber

4 University Hospital Olomouc, Department of Hemato-Oncology, Olomouc, Czech Republic

Tomas Papajik

4 University Hospital Olomouc, Department of Hemato-Oncology, Olomouc, Czech Republic

Ivana Skoumalova

4 University Hospital Olomouc, Department of Hemato-Oncology, Olomouc, Czech Republic

Michal Karas

5 University Hospital Pilsen, Hematology and Oncology Department, Plzen-Lochotin, Czech Republic

Pavel Jindra

5 University Hospital Pilsen, Hematology and Oncology Department, Plzen-Lochotin, Czech Republic

Hana Klamová

6 Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Cyril Salek

6 Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Dana Srbová

6 Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Hana Zizkova

6 Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Lukas Stejskal

7 University Hospital Ostrava, Department of Hemato-Oncology, Ostrava-Poruba, Czech Republic

Olga Cerna

8 University Hospital Kralovske Vinohrady, Department of Internal Medicine and Hematology, Prague, Czech Republic

Eduard Cmunt

9 General University Hospital in Prague, 1st Dep. of Medicine - Dep. of Hematology, Prague, Czech Republic

Petra Cicatkova

1 University Hospital Brno, Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic

Anezka Kvetkova

1 University Hospital Brno, Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic

Tomas Hornak

1 University Hospital Brno, Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic

Ivana Jeziskova

1 University Hospital Brno, Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic

Tomas Jurcek

1 University Hospital Brno, Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic

Barbora Weinbergerová

1 University Hospital Brno, Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic

Jirina Prochazkova

1 University Hospital Brno, Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic

Katerina Machova Polakova

6 Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Adam Svobodnik

2 Masaryk University, Faculty of Medicine, Brno, Czech Republic

Radka Stepanova

2 Masaryk University, Faculty of Medicine, Brno, Czech Republic

Jiri Mayer

1 University Hospital Brno, Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic